NEW YORK / RankWire.AI / – According to a systematic review and meta-analysis conducted in 2024, the organization behind the research examined 19 randomized controlled trials involving 962 adults. Researchers, including experts from Isfahan University of Medical Sciences, compared the effects of psyllium supplementation to placebo or control treatments. Their findings showed that psyllium reduced fasting blood sugar by an average of 6.89 mg/dL and decreased HbA1c by 0.75 percentage points across the combined studies. Additionally, improvements in HOMA-IR, an indicator of insulin resistance, were observed. However, the analysis did not find a statistically significant decrease in circulating insulin levels.
The results also indicated that both dosage and duration of treatment could influence outcomes. Several dose ranges of psyllium yielded improvements in fasting blood sugar. Nevertheless, studies lasting fewer than 50 days did not demonstrate significant reductions in fasting glucose during subgroup analysis. HbA1c levels showed no significant change at doses below 10 grams daily. A tablespoon of psyllium may be close to that amount, though product weights can vary. Consumers are advised to review nutrition labels rather than assume that every tablespoon contains the same dose.
More pronounced benefits are observed with higher blood sugar levels
Previous clinical research has identified stronger effects among individuals already facing difficulties in blood glucose regulation. A meta-analysis of 35 randomized studies revealed the greatest reductions among participants receiving treatment for type 2 diabetes. In these studies, taking psyllium before meals lowered fasting glucose by an average of 37 mg/dL, with HbA1c decreasing by 0.97 percentage points. The analysis also noted minimal glucose-lowering effects among individuals with normal blood sugar levels. Participants with prediabetes experienced smaller improvements compared to those diagnosed with diabetes.
Another clinical trial involving 40 adults with type 2 diabetes spanned eight weeks. Participants in the intervention group consumed approximately 10.5 grams of soluble psyllium fiber daily. The study reported enhancements in fasting glucose, HbA1c, insulin levels, and insulin resistance. Given the small sample size, larger pooled studies offer more robust evidence. The current data support the potential of psyllium as a dietary supplement that could aid in managing diabetes but do not suggest it should replace prescribed treatments.
Ensuring adequate fluid intake is essential for safe use
As psyllium absorbs significant amounts of water, proper preparation is crucial. The U.S. National Library of Medicine recommends mixing psyllium powder or granules with at least 8 ounces, or about 240 milliliters, of liquid. The mixture should be consumed promptly after preparation. Increasing fiber intake rapidly may cause gas, bloating, or other digestive discomfort in some users. Insufficient fluid intake can also lead to swallowing difficulties or elevate the risk of intestinal blockage in susceptible individuals.
Furthermore, psyllium can influence the absorption or response to certain medications. Individuals taking prescription drugs are advised to consult a healthcare professional before incorporating regular psyllium supplementation. This advice is especially important for those managing blood sugar levels with medication. While psyllium may support glucose regulation, it is not a substitute for diabetes medications, ongoing monitoring, or professional healthcare. Maintaining regular physical activity, following a balanced diet, and consistent medical oversight remain vital for long-term blood sugar control.